Bone and Mineral Metabolism in Patients with Primary Aldosteronism

Primary aldosteronism represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium excretion inducing secondary increase of parathyroid hormone. Recently, i...

Full description

Saved in:
Bibliographic Details
Main Authors: Luigi Petramala, Laura Zinnamosca, Amina Settevendemmie, Cristiano Marinelli, Matteo Nardi, Antonio Concistrè, Francesco Corpaci, Gianfranco Tonnarini, Giorgio De Toma, Claudio Letizia
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2014/836529
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554560649953280
author Luigi Petramala
Laura Zinnamosca
Amina Settevendemmie
Cristiano Marinelli
Matteo Nardi
Antonio Concistrè
Francesco Corpaci
Gianfranco Tonnarini
Giorgio De Toma
Claudio Letizia
author_facet Luigi Petramala
Laura Zinnamosca
Amina Settevendemmie
Cristiano Marinelli
Matteo Nardi
Antonio Concistrè
Francesco Corpaci
Gianfranco Tonnarini
Giorgio De Toma
Claudio Letizia
author_sort Luigi Petramala
collection DOAJ
description Primary aldosteronism represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium excretion inducing secondary increase of parathyroid hormone. Recently, in a cohort of PA patients a significant increase of primary hyperparathyroidism was found, suggesting a bidirectional functional link between the adrenal and parathyroid glands. The aim of this study was to evaluate the impact of aldosterone excess on mineral metabolism and bone mass density. In 73 PA patients we evaluated anthropometric and biochemical parameters, renin-angiotensin-aldosterone system, calcium-phosphorus metabolism, and bone mineral density; control groups were 73 essential hypertension (EH) subjects and 40 healthy subjects. Compared to HS and EH, PA subjects had significantly lower serum calcium levels and higher urinary calcium excretion. Moreover, PA patients showed higher plasma PTH, lower serum 25(OH)-vitamin D levels, higher prevalence of vitamin D deficiency (65% versus 25% and 25%; P<0.001), and higher prevalence of osteopenia/osteoporosis (38.5 and 10.5%) than EH (28% and 4%) and NS (25% and 5%), respectively. This study supports the hypothesis that bone loss and fracture risk in PA patients are potentially the result of aldosterone mediated hypercalciuria and the consecutive secondary hyperparathyroidism.
format Article
id doaj-art-43bbb1725d8a486bb0dcba1932b8e458
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-43bbb1725d8a486bb0dcba1932b8e4582025-02-03T05:51:03ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/836529836529Bone and Mineral Metabolism in Patients with Primary AldosteronismLuigi Petramala0Laura Zinnamosca1Amina Settevendemmie2Cristiano Marinelli3Matteo Nardi4Antonio Concistrè5Francesco Corpaci6Gianfranco Tonnarini7Giorgio De Toma8Claudio Letizia9Internal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyDepartment of Surgery, P.Valdoni, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyInternal Medicine and Secondary Hypertension Unit, Department of Internal Medicine and Medical Specialties, University of Rome La Sapienza, Viale del Policlinico 155, 00165 Rome, ItalyPrimary aldosteronism represents major cause of secondary hypertension, strongly associated with high cardiovascular morbidity and mortality. Aldosterone excess may influence mineral homeostasis, through higher urinary calcium excretion inducing secondary increase of parathyroid hormone. Recently, in a cohort of PA patients a significant increase of primary hyperparathyroidism was found, suggesting a bidirectional functional link between the adrenal and parathyroid glands. The aim of this study was to evaluate the impact of aldosterone excess on mineral metabolism and bone mass density. In 73 PA patients we evaluated anthropometric and biochemical parameters, renin-angiotensin-aldosterone system, calcium-phosphorus metabolism, and bone mineral density; control groups were 73 essential hypertension (EH) subjects and 40 healthy subjects. Compared to HS and EH, PA subjects had significantly lower serum calcium levels and higher urinary calcium excretion. Moreover, PA patients showed higher plasma PTH, lower serum 25(OH)-vitamin D levels, higher prevalence of vitamin D deficiency (65% versus 25% and 25%; P<0.001), and higher prevalence of osteopenia/osteoporosis (38.5 and 10.5%) than EH (28% and 4%) and NS (25% and 5%), respectively. This study supports the hypothesis that bone loss and fracture risk in PA patients are potentially the result of aldosterone mediated hypercalciuria and the consecutive secondary hyperparathyroidism.http://dx.doi.org/10.1155/2014/836529
spellingShingle Luigi Petramala
Laura Zinnamosca
Amina Settevendemmie
Cristiano Marinelli
Matteo Nardi
Antonio Concistrè
Francesco Corpaci
Gianfranco Tonnarini
Giorgio De Toma
Claudio Letizia
Bone and Mineral Metabolism in Patients with Primary Aldosteronism
International Journal of Endocrinology
title Bone and Mineral Metabolism in Patients with Primary Aldosteronism
title_full Bone and Mineral Metabolism in Patients with Primary Aldosteronism
title_fullStr Bone and Mineral Metabolism in Patients with Primary Aldosteronism
title_full_unstemmed Bone and Mineral Metabolism in Patients with Primary Aldosteronism
title_short Bone and Mineral Metabolism in Patients with Primary Aldosteronism
title_sort bone and mineral metabolism in patients with primary aldosteronism
url http://dx.doi.org/10.1155/2014/836529
work_keys_str_mv AT luigipetramala boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT laurazinnamosca boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT aminasettevendemmie boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT cristianomarinelli boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT matteonardi boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT antonioconcistre boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT francescocorpaci boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT gianfrancotonnarini boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT giorgiodetoma boneandmineralmetabolisminpatientswithprimaryaldosteronism
AT claudioletizia boneandmineralmetabolisminpatientswithprimaryaldosteronism